| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/23/2002 | US6376243 Capable of specifically hybridizing with a sequence included within the sequence of a nucleic acid molecule encoding a mammalian 5-ht4b receptor. |
| 04/23/2002 | US6376236 Alphavirus vector construct which directs the expression of a heterologous nucleic acid molecule; capsid protein; and envelope glycoprotein from a second virus different from the alphavirus of said alphavirus vector construct |
| 04/23/2002 | US6376215 JMY, a co-activator for p300/CBP, nucleic acid encoding JMY and uses thereof |
| 04/23/2002 | US6376214 DNA encoding a novel homolog of CSBP/p38 MAP kinase |
| 04/23/2002 | US6376207 Assay and reagents for quantifying hBNp |
| 04/23/2002 | US6376206 Specific antibodies to troponin T, their production and use in a reagent for the determination of myocardial necrosis |
| 04/23/2002 | US6376203 Isolated antibody immunologically reactive with mycoplasma fermentans glycoglycerophospholipid comprising glucose, fatty acid, phosphocholine and glycerol, being nonadsorptive to ion exchanger having diethylaminoethyl group, unstable to alkali |
| 04/23/2002 | US6376200 Incubating test ligand with human excitatory amino acid-4 receptor-producing cell, or derived membrane preparation, which incorporates expressibly heterologous polynucleotide encoding receptor, measuring ligand-induced electrical current |
| 04/23/2002 | US6376196 Contacting sample with isolated immunodominant neospora antigen, thereby forming antigen/antibody complex and detecting presence of antibodies specifically immunoreactive with bovine neospora antigen |
| 04/23/2002 | US6376174 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 04/23/2002 | US6375952 Isolated herpes simplex virus polypeptide |
| 04/23/2002 | US6375950 Methods for inducing T cell unresponsiveness to donor tissue or organ in a recipient with gp39 antagonists |
| 04/23/2002 | US6375949 Monoclonal antibody recognizing serum amyloid A |
| 04/23/2002 | CA2221807C Method for producing phytase |
| 04/23/2002 | CA2203765C Cathepsin o2 protease |
| 04/18/2002 | WO2002031177A2 Method for synthesising peptides, peptide mimetics and proteins |
| 04/18/2002 | WO2002031156A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 04/18/2002 | WO2002031155A2 Gene cluster for ramoplanin biosynthesis |
| 04/18/2002 | WO2002031154A1 Bzip type transcripiton factors regulating the expression of rice storage protein |
| 04/18/2002 | WO2002031151A2 Lipocalins |
| 04/18/2002 | WO2002031146A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | WO2002031140A1 Cells producing antibody compositions |
| 04/18/2002 | WO2002031137A2 Cytomegalovirus intron a fragments |
| 04/18/2002 | WO2002030987A1 Antihuman heme oxygenase-1 monoclonal antibody |
| 04/18/2002 | WO2002030981A1 Gene encoding a human g-protein coupled receptor and its use |
| 04/18/2002 | WO2002030965A2 Nucleic acids encoding stichodactylidae chromoproteins |
| 04/18/2002 | WO2002030964A2 Comparative ligand mapping from mhc positive cells |
| 04/18/2002 | WO2002030963A1 Human ect2 and methods of use |
| 04/18/2002 | WO2002030958A2 Casein peptide fragments with growth-influencing activity on cell cultures |
| 04/18/2002 | WO2002014499A9 Claudin polypeptides |
| 04/18/2002 | WO2002008272A3 High affinity soluble interleukin-18 receptor |
| 04/18/2002 | WO2002008252A3 Novel protein containing ring finger domaine r1p4 |
| 04/18/2002 | WO2002004007A3 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof |
| 04/18/2002 | WO2002000914A3 Bioengineered vehicles for targeted nucleic acid delivery |
| 04/18/2002 | WO2001083744A3 Natrium-calcium exchanger protein |
| 04/18/2002 | WO2001083707A3 Chondrocyte cultures and anti-angiogenic fractions therefrom |
| 04/18/2002 | WO2001081574A3 Regulation of nf-at interacting protein nip 45 variant |
| 04/18/2002 | WO2001081409A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001066595A3 Human fgf-23 gene and gene expression products |
| 04/18/2002 | WO2001064876A3 Human schizophrenia gene |
| 04/18/2002 | WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof |
| 04/18/2002 | WO2001058916A3 Antibodies to ccr5 |
| 04/18/2002 | WO2001053330A3 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them |
| 04/18/2002 | WO2001051520A3 Nogo receptor-mediated blockade of axonal growth |
| 04/18/2002 | WO2001040271A3 Cancer associated antigens and uses therefor |
| 04/18/2002 | WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2000068387A9 Nucleic acids and proteins with interferon-beta activity |
| 04/18/2002 | WO2000068385A9 Novel nucleic acids and proteins with growth hormone activity |
| 04/18/2002 | WO2000067793A9 Death domain containing receptor 4 |
| 04/18/2002 | US20020046416 Plant proteins |
| 04/18/2002 | US20020046412 Use for finding active compounds for crop protection |
| 04/18/2002 | US20020045737 Enterococcus faecalis polynucleotides and polypeptides |
| 04/18/2002 | US20020045734 Geneticaly engineered polypeptide for use drug delivery tools |
| 04/18/2002 | US20020045577 Human schizophrenia gene |
| 04/18/2002 | US20020045567 Synthetic proteins for in vivo drug delivery and tissue augmentation |
| 04/18/2002 | US20020045273 Test methods and devices |
| 04/18/2002 | US20020045264 Expression vectors for use in gene therapy |
| 04/18/2002 | US20020045255 Method of making glycoprotein exhibiting erythropoiesis regulating activity and glycoprotein produced by this method |
| 04/18/2002 | US20020045241 T cells specific for kidney carcinoma |
| 04/18/2002 | US20020045234 Expression system |
| 04/18/2002 | US20020045229 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 04/18/2002 | US20020045219 Generating hybrid cell expresses telomerase; obtain cells, fuse, transform cells, monitor cell for expression of telomerase |
| 04/18/2002 | US20020045217 Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 04/18/2002 | US20020045215 Isolation and characterization of a rat epidermal growth factor related protein |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
| 04/18/2002 | US20020045211 Plasmid for use in the generation of genetically engineered amino acid sequences |
| 04/18/2002 | US20020045208 Nucleotide sequences which code polypeptides for use in treatment of autoimmune diseases, allergies and tumors |
| 04/18/2002 | US20020045207 Glycoprotein production process |
| 04/18/2002 | US20020045201 Sreening drugs for use in treatment of nervous system disorders; obtain protein sample, mix with modulator, monitor complex formation, compare to control, adjustment in concentration of preferential complex indicates modulator |
| 04/18/2002 | US20020045193 Polypeptide for use in purifying and separation of target peptides |
| 04/18/2002 | US20020045167 Used for detecting incomplete deprotection of a synthetic oligonucleotide by immunoassay |
| 04/18/2002 | US20020045166 Peptides; for use as tools in gene therapy |
| 04/18/2002 | US20020045164 Reagents and methods useful for detecting diseases of the lung |
| 04/18/2002 | US20020044950 Recombinant toxin fragments |
| 04/18/2002 | US20020044937 Where the protein binds to T-cell cell surface protein, and that complex with nucleic acids, for transporting nucleic acids into human or animal cells which express the T-cell surface protein; antisense therapy, HIV therapy |
| 04/18/2002 | US20020044936 Administering a monoclonal antibody or fragment thereof which acts as an antagonist of the integrins GPIIb/IIIa ( alpha IIb beta 3) and alpha v beta 3; also treating inflammatory diseases such as rheumatoid arthritis, psoriasis |
| 04/18/2002 | US20020044930 Severe combined immunodeficiency disease (SCID); immunotherapy of human diseases such as prostate cancer |
| 04/18/2002 | DE10047857A1 Verfahren zur selektiven biokatalytischen Modifizierung von Peptiden und Proteinen Biocatalytic process for the selective modification of peptides and proteins |
| 04/18/2002 | CA2785941A1 Antibody composition-producing cell |
| 04/18/2002 | CA2425767A1 Lipocalins |
| 04/18/2002 | CA2425671A1 Human ect2 and methods of use |
| 04/18/2002 | CA2425318A1 Far red shifted fluorescent proteins |
| 04/18/2002 | CA2425298A1 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | CA2424821A1 Gene encoding a human g-protein coupled receptor and its use |
| 04/18/2002 | CA2424433A1 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 04/17/2002 | EP1197557A1 Gene encoding cyclic lipopeptide acylase and expression of the same |
| 04/17/2002 | EP1197554A1 Proliferation differentiation factor |
| 04/17/2002 | EP1197496A1 Novel peptides |
| 04/17/2002 | EP1197220A2 Therapeutic methods and compositions based on delta proteins and nucleic acids |
| 04/17/2002 | EP1196772A2 Induction of a th1-like response in vitro |
| 04/17/2002 | EP1196608A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 04/17/2002 | EP1196598A1 Dsp-3 dual-specificity phosphatase |
| 04/17/2002 | EP1196586A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 04/17/2002 | EP1196584A1 Tetanus toxin polypeptides |
| 04/17/2002 | EP1196583A2 GENOME SEQUENCE AND POLYPEPTIDES OF PYROCOCCUS $i(ABISSY), FRAGMENT AND USES THEREOF |
| 04/17/2002 | EP1196579A2 Tryptase inhibitor |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196575A2 Gtp-binding protein associated factors |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |